Fukumoto Kenichi, Fogaça Manoela V, Liu Rong-Jian, Duman Catharine H, Li Xiao-Yuan, Chaki Shigeyuki, Duman Ronald S
Departments of Psychiatry and Neurosciences, Yale University School of Medicine, 34 Park Street, New Haven, CT, 06520, USA.
Research Headquarters, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama, Saitama, 331-9530, Japan.
Neuropsychopharmacology. 2020 Sep;45(10):1725-1734. doi: 10.1038/s41386-020-0705-0. Epub 2020 May 12.
We previously reported that the serotonergic system is important for the antidepressant-like effects of ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, which produces rapid and long-lasting antidepressant effects in patients with major depressive disorder (MDD). In particular, selective stimulation of the 5-HT receptor in the medial prefrontal cortex (mPFC), as opposed to the somatic 5-HT autoreceptor, has been shown to play a critical role in the antidepressant-like actions of ketamine. However, the detailed mechanisms underlying mPFC 5-HT receptor-mediated antidepressant-like effects are not fully understood. Here we examined the involvement of the glutamate AMPA receptor and brain-derived neurotrophic factor (BDNF) in the antidepressant-like effects of 5-HT receptor activation in the mPFC. The results show that intra-mPFC infusion of the 5-HT receptor agonist 8-OH-DPAT induces rapid and long-lasting antidepressant-like effects in the forced swim, novelty-suppressed feeding, female urine sniffing, and chronic unpredictable stress tests. In addition, the results demonstrate that the antidepressant-like effects of intra-mPFC infusion of 8-OH-DPAT are blocked by co-infusion of an AMPA receptor antagonist or an anti-BDNF neutralizing antibody. In addition, mPFC infusion of 8-OH-DPAT increased the phosphorylation of signaling proteins downstream of BDNF, including mTOR, ERK, 4EBP1, and p70S6K. Finally, selective stimulation of the 5-HT receptor increased levels of synaptic proteins and synaptic function in the mPFC. Collectively, these results indicate that selective stimulation of 5-HT receptor in the mPFC exerts rapid and sustained antidepressant-like effects via activation of AMPA receptor/BDNF/mTOR signaling in mice, which subsequently increase synaptic function in the mPFC, and provide evidence for the 5-HT receptor as a target for the treatment of MDD.
我们之前报道过,血清素能系统对于氯胺酮的抗抑郁样作用很重要,氯胺酮是一种非竞争性N-甲基-D-天冬氨酸受体拮抗剂,可在重度抑郁症(MDD)患者中产生快速且持久的抗抑郁作用。特别是,与躯体5-羟色胺自身受体相反,内侧前额叶皮质(mPFC)中5-羟色胺受体的选择性刺激已被证明在氯胺酮的抗抑郁样作用中起关键作用。然而,mPFC 5-羟色胺受体介导的抗抑郁样作用的详细机制尚未完全了解。在这里,我们研究了谷氨酸AMPA受体和脑源性神经营养因子(BDNF)在mPFC中5-羟色胺受体激活的抗抑郁样作用中的参与情况。结果表明,向mPFC内注射5-羟色胺受体激动剂8-OH-DPAT可在强迫游泳、新奇抑制摄食、雌性尿液嗅探和慢性不可预测应激试验中诱导快速且持久的抗抑郁样作用。此外,结果表明,向mPFC内注射8-OH-DPAT的抗抑郁样作用可被同时注射AMPA受体拮抗剂或抗BDNF中和抗体所阻断。此外,向mPFC内注射8-OH-DPAT可增加BDNF下游信号蛋白的磷酸化,包括mTOR、ERK、4EBP1和p70S6K。最后,5-羟色胺受体的选择性刺激增加了mPFC中突触蛋白的水平和突触功能。总的来说,这些结果表明,mPFC中5-羟色胺受体的选择性刺激通过激活小鼠中的AMPA受体/BDNF/mTOR信号传导发挥快速且持续的抗抑郁样作用,随后增加mPFC中的突触功能,并为5-羟色胺受体作为治疗MDD的靶点提供了证据。